AP-1-clustered sites are present only in the promoter of claudin 4, but the mRNA of this claudin is not upregulated in CMS3 or CMS1 cancers where the KRAS/MAPK pathway is mostly activated due to activating KRAS and BRAF mutations, respectively. Here, CLDN4 is linked to cancer.